Mediterranean Journal of Infection Microbes and Antimicrobials

Scope & Guideline

Connecting researchers to combat microbial threats.

Introduction

Immerse yourself in the scholarly insights of Mediterranean Journal of Infection Microbes and Antimicrobials with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2147-673x
PublisherGALENOS PUBL HOUSE
Support Open AccessYes
CountryTurkey
TypeJournal
Convergefrom 2018 to 2023
AbbreviationMEDITERR J INFECT M / Mediterr. J. Infect. Microbes Antimicrob.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The Mediterranean Journal of Infection Microbes and Antimicrobials focuses on advancing knowledge in the fields of infectious diseases, microbiology, and antimicrobial therapy. It aims to provide a platform for researchers and clinicians to share their findings and insights related to various pathogens, treatment methodologies, and epidemiological trends.
  1. Infectious Disease Epidemiology:
    Research articles examining the prevalence, risk factors, and outcomes associated with infectious diseases across diverse populations, particularly in the Mediterranean region.
  2. Microbial Pathogenesis and Resistance:
    Studies exploring the mechanisms of pathogenicity of microorganisms, as well as their resistance patterns to antibiotics and antifungals, contributing to the understanding of treatment challenges.
  3. Clinical Microbiology and Diagnostics:
    Papers focused on laboratory diagnostics, including innovative techniques for identifying pathogens and evaluating their antimicrobial susceptibility, which are crucial for effective treatment strategies.
  4. Therapeutic Interventions and Outcomes:
    Research evaluating the efficacy and safety of various therapeutic interventions for infectious diseases, including novel antibiotics, antiviral agents, and antifungal therapies.
  5. Emerging Infections and Public Health:
    Investigations into new and re-emerging infections, their impact on public health, and the responses required to manage outbreaks, especially in the context of global health challenges.
The journal has witnessed a rise in interest in several key areas that reflect current global health challenges and advancements in research methodologies. These emerging themes signify a response to evolving infectious disease landscapes.
  1. COVID-19 Research:
    A significant increase in studies related to COVID-19, including epidemiology, clinical outcomes, and vaccine efficacy, reflects the urgent need to understand and combat this global pandemic.
  2. Antimicrobial Stewardship:
    Emerging research on antimicrobial stewardship practices highlights efforts to optimize the use of antibiotics and antifungals in clinical settings, aiming to combat the growing threat of resistance.
  3. Fungal Infections and Antifungal Resistance:
    There is a notable uptick in research focused on invasive fungal infections and their management, particularly in immunocompromised patients, as well as studies addressing antifungal resistance patterns.
  4. Artificial Intelligence in Diagnostics:
    The integration of artificial intelligence and machine learning in the diagnosis and management of infections is becoming increasingly prevalent, indicating a trend toward leveraging technology for improved patient care.
  5. Global Health Perspectives:
    Research incorporating global health perspectives, particularly in relation to infectious disease outbreaks and their socio-economic impacts, is gaining traction, reflecting an interdisciplinary approach to public health.

Declining or Waning

While the journal maintains a broad focus, certain themes have shown a decline in prominence in recent years. This may reflect shifting research priorities or a saturation of studies in these areas.
  1. Traditional Antibiotic Therapy:
    There has been a noticeable decrease in studies focusing solely on traditional antibiotics without considering newer agents or combination therapies, as the field increasingly shifts toward addressing antibiotic resistance and exploring innovative treatment options.
  2. Non-communicable Disease Infections:
    Research on infections related to non-communicable diseases appears to be waning, possibly due to a greater emphasis on acute infectious diseases, especially in light of recent global health crises.
  3. Basic Laboratory Techniques:
    Papers detailing basic laboratory methodologies and techniques may be declining as the field moves towards more advanced and automated diagnostic methods, reflecting a shift in research focus towards clinical applications and outcomes.

Similar Journals

Lancet Microbe

Fostering Collaboration for a Healthier Tomorrow
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

JOURNAL OF INFECTION

Cultivating Expertise in Medical Microbiology
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

Gut Pathogens

Unlocking Insights for Better Gut Health
Publisher: BMCISSN: 1757-4749Frequency: 1 issue/year

Gut Pathogens, published by BMC in the United Kingdom, is a premier open-access journal focusing on the intersection of gut health and infectious diseases. With its impact firmly established since its inception in 2009, the journal has earned impressive rankings, including Q1 in renowned categories such as Gastroenterology, Infectious Diseases, Microbiology, and Parasitology, while maintaining a strong presence in Virology. The journal serves as a vital resource for researchers, professionals, and students interested in the intricate relationships between gut microbiota and pathogenic organisms, offering insights that drive advancements in treatment and prevention strategies. By providing unrestricted access to high-quality research, Gut Pathogens fosters a collaborative environment, encouraging the dissemination of knowledge and innovation within the field. The journal publishes original research, reviews, and case studies, all designed to address contemporary challenges in gut health, ultimately aiming to improve patient outcomes and public health worldwide.

MICROBIAL PATHOGENESIS

Advancing the Science of Microbial Infections
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0882-4010Frequency: 12 issues/year

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

Microbiology Spectrum

Bridging disciplines in the realm of microbiological studies.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

CLINICAL MICROBIOLOGY REVIEWS

Elevating clinical practices through expert reviews.
Publisher: AMER SOC MICROBIOLOGYISSN: 0893-8512Frequency: 4 issues/year

CLINICAL MICROBIOLOGY REVIEWS, published by the American Society for Microbiology, is a leading journal in the fields of epidemiology, immunology, and microbiology, notably recognized for its Q1 status in multiple categories such as Infectious Diseases and Public Health. With an ISSN of 0893-8512 and E-ISSN of 1098-6618, this esteemed journal offers comprehensive reviews and analyses that contribute to the advancement of clinical microbiology practices worldwide. Since its inception in 1988, it has established itself as a pivotal resource for researchers and healthcare professionals, delivering high-quality, peer-reviewed articles that are instrumental in understanding microbial diseases. The journal is highly regarded in the academic community, boasting impressive Scopus rankings, including Rank #1 in Medical Microbiology and a commendable 99th percentile in Public Health. Although not available as an open-access publication, CLINICAL MICROBIOLOGY REVIEWS remains an essential tool for those seeking to enhance their knowledge and practice in microbiology, making significant impacts on clinical outcomes and public health initiatives.

BRAZILIAN JOURNAL OF MICROBIOLOGY

Exploring the Microbial World for a Healthier Tomorrow
Publisher: SPRINGERISSN: 1517-8382Frequency: 4 issues/year

The BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.

JOURNAL OF CLINICAL MICROBIOLOGY

Exploring the Microbial Landscape of Human Health
Publisher: AMER SOC MICROBIOLOGYISSN: 0095-1137Frequency: 12 issues/year

JOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Pioneering Discoveries in Infectious Disease Research
Publisher: ELSEVIER SCI LTDISSN: 0147-9571Frequency: 6 issues/year

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

MIKROBIYOLOJI BULTENI

Unveiling the Complexities of Microbial Life
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.